<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Pharmacological tests, dynamic hepatoscintigraphy, spectrophotometric evaluation of serum and bile content of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> fractions were performed in examination of 136 patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e> (group 1), <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, <z:hpo ids='HP_0001397'>steatosis</z:hpo> or <z:hpo ids='HP_0001394'>hepatic cirrhosis</z:hpo> (group 2) and 23 patients free of hepatic pathology (control group) </plain></SENT>
<SENT sid="1" pm="."><plain>It was established that androgenic steroids have effect on <z:chebi fb="0" ids="16990">bilirubin</z:chebi>-glucuronidation </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002904'>Hyperbilirubinemia</z:hpo> in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert syndrome</z:e> can be caused not only inhibition of <z:chebi fb="0" ids="16990">bilirubin</z:chebi>-glucuronidation in the liver but also defective uptake of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> by hepatocytes </plain></SENT>
</text></document>